Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: Postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens

Parasitology

Volumn 121, Issue 3, 2000, Pages 237-246

  Hoshen, M B ^a   Na Bangchang, K ^b   Stein, W D ^a   Ginsburg, H ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Artesunate; Dormancy; Mathematical model; Pharmacodynamics; Pharmacokinetics; Plasmodium falciparum malaria

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; FANSIDAR; MEFLOQUINE;

ANTIMALARIAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; HUMAN; LIFE CYCLE; MALARIA; MATHEMATICAL MODEL; MULTIDRUG RESISTANCE; NONHUMAN; PARASITEMIA; PLASMODIUM; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; ARTEMISININS; COMPUTER SIMULATION; HUMANS; MALARIA, FALCIPARUM; MODELS, BIOLOGICAL; PARASITEMIA; PLASMODIUM FALCIPARUM; SESQUITERPENES; THAILAND;

ARTESUNATE; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0033844213     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0031182099006332     Document Type: Article

References (41)

1. Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria
2. Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria
3. A pharmacokinetic and pharmacodynamic study of intravenous vs. oral artesunate in uncomplicated falciparum malaria
4. Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria
5. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report
6. Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria
7. Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria
8. Artemether or artesunate followed by mefloquine as a possible treatment for multidrug resistant falciparum malaria
9. Repetitive dosing of artemisinin and quinine against Plasmodium falciparum in vitro: A simulation of the in vivo pharmacokinetics
10. Efficacy of artemisinin and mefloquine combinations against Plasmodium falciparum. In vitro simulation of in vivo pharmacokinetics
11. Measurement of Plasmodium falciparum growth rates in vivo: Test of malaria vaccines
12. Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture
13. Single dose artemisinin mefloquine treatment for acute uncomplicated falciparum malaria
14. Modelling the chloroquine chemotherapy of falciparum malaria: The value of spacing a split dose
15. Single dose artemisinin-mefloquine versus mefloquine alone for uncomplicated falciparum malaria
16. Pharmacokinetics of mefloquine alone or in combination with artesunate
17. Pharmacokinetics of oral artesunate in Thai patients with uncomplicated falciparum malaria
18. Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro
19. Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine
20. Efficacy and tolerability of a sequential, artesunate suppository plus mefloquine, treatment of severe falciparum malaria
21. Artemether-pyrimethamine in the treatment of pyrimethamine-resistant falciparum malaria
22. Pharmacokinetic and bioequivalence evaluation of two generic formulations of oral artesunate
23. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate mefloquine combination
24. Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria
25. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria
26. Artesunate and mafloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria
27. Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria
28. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania
29. Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria
30. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs
31. Plasmodium falciparum : In vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria
32. Randomized comparison of artemether-benflumetol and artesunate- mefloquine in treatment of multidrug-resistant falciparum malaria
33. Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting
34. Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef
35. Epidemiology of drug resistance in malaria
36. The effects of multiplication and synchronicity on the vascular distribution of parasites in falciparum malaria
37. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives
38. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo
39. Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria
40. Emergence of multidrug-resistant Plasmodium falciparum in Thailand: In vitro tracking